Skip to content 
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. more
| Time Frame | BSX | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 0.65% | 1.51% | -1.5% |
| 1-Month Return | -18.06% | 1.46% | 0.6% |
| 3-Month Return | -26.56% | 3.94% | 2.43% |
| 6-Month Return | -27.48% | 16.03% | 6.01% |
| 1-Year Return | -29.07% | 9.1% | 11.48% |
| 3-Year Return | 60.57% | 19.46% | 67.52% |
| 5-Year Return | 99.28% | 35.29% | 73.75% |
| 10-Year Return | 325.33% | 137.42% | 254.46% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 11.89B | 12.68B | 14.24B | 16.75B | 20.07B | [{"date":"2021-12-31","value":59.22,"profit":true},{"date":"2022-12-31","value":63.18,"profit":true},{"date":"2023-12-31","value":70.94,"profit":true},{"date":"2024-12-31","value":83.43,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Cost of Revenue | 4.43B | 4.97B | 5.41B | 6.48B | 6.22B | [{"date":"2021-12-31","value":68.32,"profit":true},{"date":"2022-12-31","value":76.67,"profit":true},{"date":"2023-12-31","value":83.47,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":96,"profit":true}] |
| Gross Profit | 7.46B | 7.71B | 8.83B | 10.27B | 13.85B | [{"date":"2021-12-31","value":53.86,"profit":true},{"date":"2022-12-31","value":55.68,"profit":true},{"date":"2023-12-31","value":63.75,"profit":true},{"date":"2024-12-31","value":74.11,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Margin | 62.76% | 60.83% | 62.02% | 61.31% | 69.01% | [{"date":"2021-12-31","value":90.94,"profit":true},{"date":"2022-12-31","value":88.14,"profit":true},{"date":"2023-12-31","value":89.86,"profit":true},{"date":"2024-12-31","value":88.84,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Expenses | 5.54B | 5.89B | 6.65B | 7.63B | 9.88B | [{"date":"2021-12-31","value":56.05,"profit":true},{"date":"2022-12-31","value":59.6,"profit":true},{"date":"2023-12-31","value":67.29,"profit":true},{"date":"2024-12-31","value":77.23,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Income | 1.92B | 1.82B | 2.18B | 2.63B | 3.97B | [{"date":"2021-12-31","value":48.4,"profit":true},{"date":"2022-12-31","value":45.93,"profit":true},{"date":"2023-12-31","value":54.92,"profit":true},{"date":"2024-12-31","value":66.36,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Total Non-Operating Income/Expense | (1.19B) | (1.15B) | (450.00M) | (551.00M) | - | [{"date":"2021-12-31","value":-118700000000,"profit":false},{"date":"2022-12-31","value":-115300000000,"profit":false},{"date":"2023-12-31","value":-45000000000,"profit":false},{"date":"2024-12-31","value":-55100000000,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Pre-Tax Income | 1.08B | 1.14B | 1.99B | 2.28B | 3.38B | [{"date":"2021-12-31","value":31.79,"profit":true},{"date":"2022-12-31","value":33.71,"profit":true},{"date":"2023-12-31","value":58.64,"profit":true},{"date":"2024-12-31","value":67.42,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income Taxes | 36.00M | 443.00M | 393.00M | 436.00M | 493.00M | [{"date":"2021-12-31","value":7.3,"profit":true},{"date":"2022-12-31","value":89.86,"profit":true},{"date":"2023-12-31","value":79.72,"profit":true},{"date":"2024-12-31","value":88.44,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income After Taxes | 1.04B | 698.00M | 1.59B | 1.85B | - | [{"date":"2021-12-31","value":56.34,"profit":true},{"date":"2022-12-31","value":37.81,"profit":true},{"date":"2023-12-31","value":86.24,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | 1.04B | 698.00M | 1.23B | 1.85B | - | [{"date":"2021-12-31","value":56.39,"profit":true},{"date":"2022-12-31","value":37.81,"profit":true},{"date":"2023-12-31","value":66.52,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 1.04B | 698.00M | 1.59B | 1.85B | 2.89B | [{"date":"2021-12-31","value":36.04,"profit":true},{"date":"2022-12-31","value":24.19,"profit":true},{"date":"2023-12-31","value":55.2,"profit":true},{"date":"2024-12-31","value":64.24,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| EPS (Diluted) | 1.63 | 1.75 | 2.05 | 2.51 | 3.05 | [{"date":"2021-12-31","value":53.44,"profit":true},{"date":"2022-12-31","value":57.38,"profit":true},{"date":"2023-12-31","value":67.21,"profit":true},{"date":"2024-12-31","value":82.3,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| BSX | |
|---|---|
| ROA (LTM) | 5.76% |
| ROE (LTM) | 12.68% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| BSX | |
|---|---|
| Trailing PE | 38.52 |
| Forward PE | 21.55 |
| P/S (TTM) | 5.52 |
| P/B | 4.74 |
| Price/FCF | 95 |
| EV/R | 6.06 |
| EV/Ebitda | 26.26 |
| PEG | 0.83 |
Boston Scientific Corp (BSX) share price today is $76.29
Yes, Indians can buy shares of Boston Scientific Corp (BSX) on Vested. To buy
Yes, you can purchase fractional shares of Boston Scientific Corp (BSX) via the Vested app. You can start investing in Boston Scientific Corp (BSX) with a minimum investment of $1.
You can invest in shares of Boston Scientific Corp (BSX) via Vested in three simple steps:
The 52-week high price of Boston Scientific Corp (BSX) is $109.5. The 52-week low price of Boston Scientific Corp (BSX) is $72.69.
The price-to-earnings (P/E) ratio of Boston Scientific Corp (BSX) is
The price-to-book (P/B) ratio of Boston Scientific Corp (BSX) is 4.74
The dividend yield of Boston Scientific Corp (BSX) is 0.00%
The market capitalization of Boston Scientific Corp (BSX) is $110.83B
The stock symbol (or ticker) of Boston Scientific Corp is BSX
Consider the share price of Boston Scientific Corp as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Boston Scientific Corp has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Boston Scientific Corp shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Boston Scientific Corp stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Boston Scientific Corp and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Boston Scientific Corp stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
